Approval · Notice of Compliance 28375 · 2022
CUTAQUIG: Notice of Compliance 28375
Issued June 9, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28375
- Date
- June 9, 2022
- Company
- Octapharma Pharmazeutika Produktionsges M B HVienna, Vienne, Austria
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUTAQUIG | Not yet assigned | — |
Medicinal ingredients
- IMMUNOGLOBULIN G (HUMAN) 1 G per 6ML
- IMMUNOGLOBULIN G (HUMAN) 1.65 G per 10ML
- IMMUNOGLOBULIN G (HUMAN) 2 G per 12ML
- IMMUNOGLOBULIN G (HUMAN) 3.3 G per 20ML
- IMMUNOGLOBULIN G (HUMAN) 4 G per 24ML
- IMMUNOGLOBULIN G (HUMAN) 8 G per 48ML